Reversal of P-glycoprotein-associated multidrug resistance by ivermectin

Biochemical Pharmacology
J F PouliotE Georges

Abstract

P-Glycoprotein (P-gp) causes a multidrug resistance (MDR) phenotype in tumour cells. In some cancers, the expression of P-gp has been correlated with low clinical response to chemotherapy and survival of patients. Previous studies have shown that certain lipophilic drugs bind to P-gp and reverse the MDR phenotype of tumour cells. In this study, we extend that list of compounds and present evidence for the capacity of a potent and clinically safe anthelmintic, ivermectin (IVM), as an MDR-reversing drug. Using a highly drug-resistant human cell line, we compared IVM with other MDR-reversing agents and showed that IVM is 4- and 9-fold more potent than cyclosporin A and verapamil, respectively. The capacity of IVM to inhibit iodoaryl-azidoprazosin photolabeling of P-gp is consistent with direct binding to P-gp. Studies showed that [3H]IVM binding to membranes from resistant cells is specific and saturable with KD and Bmax values of 10.6 nM and 19.8 pmol/mg, respectively. However, while cyclosporin A or vinblastine inhibited [3H]IVM binding to membranes from drug-resistant but not drug-sensitive cells, neither verapamil nor colchicine had any effect. Furthermore, both IVM and cyclosporin A and, to a lesser extent, verapamil also inh...Continue Reading

References

Jan 1, 1992·Annual Review of Cell Biology·C F Higgins
Dec 5, 1991·The New England Journal of Medicine·H S ChanV Ling
Jan 16, 1991·Journal of the National Cancer Institute·G D PennockS E Salmon
Jun 1, 1991·American Journal of Clinical Oncology·J R MurrenJ C Marsh
Jan 18, 1989·Journal of the National Cancer Institute·L J GoldsteinG M Brodeur
Jul 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·H L PearceW T Beck
Jan 1, 1989·Annual Review of Biochemistry·J A Endicott, V Ling
Jul 15, 1989·Biochemical Pharmacology·J M Schaeffer, H W Haines
Jun 1, 1995·American Journal of Clinical Oncology·E WarnerK L Skorecki
Jan 1, 1994·Investigational New Drugs·N H Patel, M L Rothenberg
Jan 1, 1993·Annual Review of Biochemistry·M M Gottesman, I Pastan

❮ Previous
Next ❯

Citations

Jun 21, 2007·Veterinary Research Communications·David J Brayden, Joanna Griffin
Jan 22, 2004·Biochemical and Biophysical Research Communications·Ying WangElias Georges
Jul 5, 2005·Molecular and Biochemical Parasitology·Bernadette F ArdelliRoger K Prichard
Feb 1, 2003·European Journal of Pharmacology·Alain RouletThierry Pineau
Sep 27, 2003·Molecular and Biochemical Parasitology·William J BlackhallRobin N Beech
May 5, 1998·Molecular and Biochemical Parasitology·M XuR Prichard
Nov 6, 1998·Molecular and Biochemical Parasitology·W J BlackhallR N Beech
Sep 25, 1999·Molecular and Biochemical Parasitology·Y J Huang, R K Prichard
Aug 23, 2001·Veterinary Parasitology·R Prichard, A Tait
Mar 8, 2003·Veterinary Parasitology·J DupuyM Alvinerie
Aug 24, 1999·Veterinary Parasitology·T G GearyD P Thompson
Sep 19, 2003·International Journal of Antimicrobial Agents·Dominique KerboeufGeorg von Samson-Himmelstjerna
Jul 1, 1997·The Veterinary Journal·R Prichard
Dec 22, 1998·Journal of Helminthology·M H RoosJ A Lenstra
Feb 13, 2001·British Journal of Pharmacology·S NobmannG Fricker
May 10, 2002·Journal of Veterinary Pharmacology and Therapeutics·A LifschitzC Lanusse
Jul 8, 1997·Proceedings of the National Academy of Sciences of the United States of America·R D NewcombJ G Oakeshott
May 15, 2003·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·Aqel W Abu-QareMohamed B Abou-Donia
Jan 2, 2007·Transplantation·James B BarnardNizar Yonan
Jan 15, 2008·Pharmacogenetics and Genomics·Maria de Lourdes Mottier, Roger K Prichard
Feb 9, 2011·Antimicrobial Agents and Chemotherapy·Dominique Kerboeuf, Fabrice Guégnard
Oct 16, 2001·Antimicrobial Agents and Chemotherapy·D A van SchalkwykP J Smith
Jul 8, 2014·European Journal of Pharmacology·Mélanie AlbérichAnne Lespine
Dec 10, 2013·Veterinary Parasitology·Carlos LanusseAdrian Lifschitz
Jan 30, 2016·Parasites & Vectors·Pablo GodoyRoger K Prichard
Feb 7, 2013·Molecular and Biochemical Parasitology·Janina DemelerGeorg von Samson-Himmelstjerna
Jul 27, 2010·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Wensheng XiangXiangjing Wang
Jun 2, 2010·Chemico-biological Interactions·Jacques DupuyAnne Lespine
Jul 29, 2008·Veterinary Parasitology·Michel AlvinerieAnne Lespine
Jan 25, 2008·Molecular and Biochemical Parasitology·Catherine BourguinatRoger K Prichard
Jan 24, 2007·Trends in Parasitology·Luis I AlvarezCarlos E Lanusse
Dec 1, 2006·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Anne LespineMichel Alvinerie

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.